You are currently on a failover version of the Materials Cloud Archive hosted at CINECA, Italy.
Click here to access the main Materials Cloud Archive.
Note: If the link above redirects you to this page, it means that the Archive is currently offline due to maintenance. We will be back online as soon as possible.
This version is read-only: you can view published records and download files, but you cannot create new records or make changes to existing ones.

Crystal structure validation of verinurad via proton-detected ultra-fast MAS NMR and machine learning


JSON Export

{
  "updated": "2024-09-17T16:10:17.050226+00:00", 
  "metadata": {
    "_oai": {
      "id": "oai:materialscloud.org:2173"
    }, 
    "version": 1, 
    "is_last": true, 
    "_files": [
      {
        "size": 511034766, 
        "checksum": "md5:179369f56a39d2f1c32c8a98e9d18047", 
        "key": "verinurad_TopSpin_data.zip", 
        "description": "Raw NMR data of the experimental spectra measured."
      }, 
      {
        "size": 3470830, 
        "checksum": "md5:e4b7342c4f2caddd1a98a8ffeaf4f69a", 
        "key": "verinurad_pip_TopSpin_data.zip", 
        "description": "Raw NMR data of the experimental spectra measured and used as input for PIPNet."
      }, 
      {
        "size": 1058281, 
        "checksum": "md5:11db59eb753daa27c3522025da5f8e1a", 
        "key": "Probabilistic_assignment.zip", 
        "description": "The input files used for the Bayesian probabilistic assignment and the complete output data generated"
      }, 
      {
        "size": 28026, 
        "checksum": "md5:b3bd8089ea7d0eb8b31a1d5a32656ce3", 
        "key": "ShiftML2_predictions.zip", 
        "description": "SXRD structure of verinurad with proton relaxed positions used as input for ShiftML2 and the Excel sheet showing the chemical shielding to chemical shift conversion"
      }, 
      {
        "size": 416390, 
        "checksum": "md5:2ec088fd922d934d39462c55dfc47b33", 
        "key": "GIPAW_calculations.zip", 
        "description": "Input/output files for proton optimization and NMR calculation"
      }
    ], 
    "keywords": [
      "Solid-State NMR", 
      "NMR crystallography", 
      "Verinurad"
    ], 
    "description": "The recent development of ultra-fast MAS (>100 kHz) provides new opportunities for structural characterization in solids. Here we use NMR crystallography to validate the structure of verinurad, a microcrystalline active pharmaceutical ingredient. To do this, we take advantage of 1H resolution improvement at ultra-fast MAS and use solely 1H-detected experiments and machine learning methods to assign all the experimental proton and carbon chemical shifts. This framework provides a new tool for elucidating chemical information from crystalline samples with limited sample volume and yields remarkably faster acquisition times compared to 13C-detected experiments, without the need to employ dynamic nuclear polarization.", 
    "contributors": [
      {
        "affiliations": [
          "Institut des Sciences et Ing\u00e9nierie Chimiques, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland"
        ], 
        "givennames": "Daria", 
        "email": "daria.torodii@epfl.ch", 
        "familyname": "Torodii"
      }, 
      {
        "affiliations": [
          "Institut des Sciences et Ing\u00e9nierie Chimiques, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland", 
          "National Centre for Computational Design and Discovery of Novel Materials MARVEL, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), Lausanne, Switzerland"
        ], 
        "givennames": "Jacob", 
        "familyname": "Holmes"
      }, 
      {
        "affiliations": [
          "Institut des Sciences et Ing\u00e9nierie Chimiques, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland"
        ], 
        "givennames": "Pinelopi", 
        "familyname": "Moutzouri"
      }, 
      {
        "affiliations": [
          "Data Science & Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, 43183 Gothenburg, Sweden"
        ], 
        "givennames": "Sten", 
        "familyname": "Nilsson Lill"
      }, 
      {
        "affiliations": [
          "Institut des Sciences et Ing\u00e9nierie Chimiques, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland", 
          "National Centre for Computational Design and Discovery of Novel Materials MARVEL, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), Lausanne, Switzerland"
        ], 
        "givennames": "Manuel", 
        "familyname": "Cordova"
      }, 
      {
        "affiliations": [
          "Swedish NMR Center, Department of Chemistry and Molecular Biology, University of Gothenburg, 41390 Gothenburg, Sweden"
        ], 
        "givennames": "Arthur", 
        "familyname": "Pinon"
      }, 
      {
        "affiliations": [
          "Bruker BioSpin GmbH & Co KG, 76275 Ettlingen, Germany"
        ], 
        "givennames": "Kristof", 
        "familyname": "Grohe"
      }, 
      {
        "affiliations": [
          "Bruker BioSpin GmbH & Co KG, 76275 Ettlingen, Germany"
        ], 
        "givennames": "Sebastian", 
        "familyname": "Wegner"
      }, 
      {
        "affiliations": [
          "Early Product Development and Manufacturing, Pharmaceutical Sciences, R&D, AstraZeneca, 43183 Gothenburg, Sweden"
        ], 
        "givennames": "Okky Dwichandra", 
        "familyname": "Putra"
      }, 
      {
        "affiliations": [
          "Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 43183 Gothenburg, Sweden"
        ], 
        "givennames": "Stefan", 
        "familyname": "Norberg"
      }, 
      {
        "affiliations": [
          "Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 43183 Gothenburg, Sweden"
        ], 
        "givennames": "Anette", 
        "familyname": "Welinder"
      }, 
      {
        "affiliations": [
          "Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 43183 Gothenburg, Sweden"
        ], 
        "givennames": "Staffan", 
        "familyname": "Schantz"
      }, 
      {
        "affiliations": [
          "Institut des Sciences et Ing\u00e9nierie Chimiques, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland", 
          "National Centre for Computational Design and Discovery of Novel Materials MARVEL, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL), Lausanne, Switzerland"
        ], 
        "givennames": "Lyndon", 
        "email": "lyndon.emsley@epfl.ch", 
        "familyname": "Emsley"
      }
    ], 
    "edited_by": 576, 
    "owner": 1355, 
    "doi": "10.24435/materialscloud:qk-x9", 
    "title": "Crystal structure validation of verinurad via proton-detected ultra-fast MAS NMR and machine learning", 
    "license": "Creative Commons Attribution 4.0 International", 
    "mcid": "2024.136", 
    "id": "2173", 
    "conceptrecid": "2172", 
    "status": "published", 
    "publication_date": "Sep 17, 2024, 18:10:17", 
    "license_addendum": null, 
    "references": [
      {
        "comment": "Paper with published SXRD structure of verinurad", 
        "type": "Journal reference", 
        "doi": "https://doi.org/10.1021/acs.oprd.1c00284", 
        "citation": "O. T. Ring, B. R. Hayter, T. O. Ronson, L. R. Agnew, I. W. Ashworth, J. Cherryman, M. A. Y. Gall, P. R. Hamilton, P. A. Inglesby, M. F. Jones, A. L. Lamacraft, A. J. Leahy, D. McKinney, L. Miller-Potucka, L. Powell, O. D. Putra, A. J. Robbins, S. Tomasi and R. A. Wordsworth, Organic Process Research & Development 26, 936-948 (2022)"
      }
    ]
  }, 
  "id": "2173", 
  "revision": 4, 
  "created": "2024-05-06T16:34:05.295959+00:00"
}